These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 26031618)
21. Population Pharmacokinetic Assessment of Vancomycin Dosing in the Large Pediatric Patient. Moffett BS; Ivaturi V; Morris J; Akcan Arikan A; Dutta A Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745380 [TBL] [Abstract][Full Text] [Related]
22. Review of vancomycin-induced renal toxicity: an update. Bamgbola O Ther Adv Endocrinol Metab; 2016 Jun; 7(3):136-47. PubMed ID: 27293542 [TBL] [Abstract][Full Text] [Related]
23. Vancomycin: a review of population pharmacokinetic analyses. Marsot A; Boulamery A; Bruguerolle B; Simon N Clin Pharmacokinet; 2012 Jan; 51(1):1-13. PubMed ID: 22149255 [TBL] [Abstract][Full Text] [Related]
24. An Update on Population Pharmacokinetic Analyses of Vancomycin, Part II: In Pediatric Patients. Aljutayli A; El-Haffaf I; Marsot A; Nekka F Clin Pharmacokinet; 2022 Jan; 61(1):47-70. PubMed ID: 34671937 [TBL] [Abstract][Full Text] [Related]
26. Vancomycin dosing in children and young adults: back to the drawing board. Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205 [TBL] [Abstract][Full Text] [Related]
27. Vancomycin dosing in obese pediatric patients. Moffett BS; Kim S; Edwards MS Clin Pediatr (Phila); 2011 May; 50(5):442-6. PubMed ID: 21282257 [TBL] [Abstract][Full Text] [Related]
28. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients. Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639 [TBL] [Abstract][Full Text] [Related]
29. Vancomycin monitoring in children using bayesian estimation. Le J; Ngu B; Bradley JS; Murray W; Nguyen A; Nguyen L; Romanowski GL; Vo T; Capparelli EV Ther Drug Monit; 2014 Aug; 36(4):510-8. PubMed ID: 24452067 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections. Pai MP; Cojutti P; Pea F Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections. Adane ED; Herald M; Koura F Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478 [TBL] [Abstract][Full Text] [Related]
32. Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings. Mahmood I Clin Pharmacokinet; 2014 Apr; 53(4):327-46. PubMed ID: 24515100 [TBL] [Abstract][Full Text] [Related]
33. Vancomycin trough concentrations in overweight or obese pediatric patients. Heble DE; McPherson C; Nelson MP; Hunstad DA Pharmacotherapy; 2013 Dec; 33(12):1273-7. PubMed ID: 23798327 [TBL] [Abstract][Full Text] [Related]
34. Prospective evaluation of the dosing regimen of vancomycin in children of different weight categories. Nassar L; Hadad S; Gefen A; Shachor-Meyouhas Y; Mashiach T; Krivoy N; Kassis I Curr Drug Saf; 2012 Nov; 7(5):375-81. PubMed ID: 23373553 [TBL] [Abstract][Full Text] [Related]
35. Improved vancomycin dosing in children using area under the curve exposure. Le J; Bradley JS; Murray W; Romanowski GL; Tran TT; Nguyen N; Cho S; Natale S; Bui I; Tran TM; Capparelli EV Pediatr Infect Dis J; 2013 Apr; 32(4):e155-63. PubMed ID: 23340565 [TBL] [Abstract][Full Text] [Related]
36. Interspecies scaling of biliary excreted drugs: prediction of human clearance and volume of distribution. Mahmood I Drug Metabol Drug Interact; 2012; 27(3):157-64. PubMed ID: 23092793 [TBL] [Abstract][Full Text] [Related]